{"title": "Find a Doctor", "author": null, "url": "https://www.dana-farber.org/find-a-doctor/brian-m-wolpin/", "hostname": "dana-farber.org", "description": "Brian M. Wolpin, MD, MPH - Medical Oncology. Dr. Wolpin received his medical degree from Harvard Medical School in 2001. He subsequently completed his residency in Internal Medicine at Brigham and Women's Hospital, and his fellowship in Medical Oncology at the Dana-Farber Cancer Institute. He joined the staff of DFCI and Brigham and Women's Hospital in ...", "sitename": "Brian M. Wolpin, MD, MPH - Dana-Farber Cancer Institute", "date": "2014-03-08", "cleaned_text": "wasting precede clinical diagnosis of pancreatic cancer. Nat Commun. 2023 07 18; 14(1):4317. wild-type Clin Cancer Res. 2023 Jul 18. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/37463056) Plasma 25-Hydroxyvitamin D Levels and Survival in Stage III Colon Cancer: Findings from CALGB/SWOG 80702 (Alliance). Clin [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/37351909) Relationship between ABO blood group alleles and pancreatic cancer is modulated by secretor 2023 [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/37342060) Genome-wide analyses characterize shared heritability among cancers and identify novel cancer susceptibility regions. J Natl Cancer Inst. 2023 FOLFIRINOX-induced neutropenia leads to systemic immune suppression in mice and humans. J Immunother Cancer. 2023 06; 11(6). View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/37344102) Highly Sensitive Circulating Tumor DNA Assay Aids Clinical Management of Radiographically Occult Isolated Peritoneal Metastases in Patients With Oncol. 7:e2200572. View in: learning algorithm to predict risk of pancreatic cancer from disease trajectories. Nat Med. 2023 05; 29(5):1113-1122. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/37156936) and Expansion Prospective Cohorts. cancer is associated with medication changes prior to clinical diagnosis. Nat Commun. 2023 04 28; 14(1):2437. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/37117188) USP9X acute adaptive response to MAPK suppression in pancreatic cancer but creates multiple actionable therapeutic vulnerabilities. Cell Rep Med. 2023 04 18; 4(4):101007. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/37030295) Polymerase ? inhibition activates the cGAS-STING pathway and cooperates with immune checkpoint blockade in models of BRCA-deficient cancer. Nat Commun. Co-expressor Phenotypes Extensive View in: of Administered With Second-Line Gemcitabine and Nab-Paclitaxel on the Survival of Patients With Pancreatic Ductal Adenocarcinoma: A Randomized Clinical 6(1):e2249720. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/36602796) Programmatic Precision Oncology 2023 Diabetes and Risk of Early- and Later-Onset Cancer: Prospective Cohort Study. Diabetes Care. 2023 01 01; 46(1):120-129. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/36399782) Emerging Role of Targeted [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/36551707) Neoadjuvant Chemotherapy Is Associated with Altered Immune Cell Infiltration and an Anti-Tumorigenic Microenvironment in Resected Pancreatic 28(23):5167-5179. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/36129461) Utility of Normalized Body Composition Areas, Derived From Outpatient Abdominal CT Using a Fully Automated Deep Learning Method, for Predicting Subsequent Cardiovascular Events. AJR Am J Roentgenol. 2022 Nov 30; and 8(9):1263-1270. View [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/35834226) 2022 11; 163(5):1170-1172. View in: cancers of the liver, biliary tract and pancreas: a prospective study within two U.S. cohorts. Br J Cancer. 2022 10; 127(6):1069-1075. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/35715632) Identification BRCA1, and PALB2 in adults with metastatic gastrointestinal cancer: a pilot and feasibility study. 07; 33(7):693-701. View in: Insight. 2022 01 25; 7(2). View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/35076021) Patterns of Adjuvant Chemotherapy Use and Association With Survival in Adults 80 Years and Older With Pancreatic in Individuals at High Risk for Pancreatic Cancer: Not a Ceiling, but Rather a Floor Upon Which to Build. Gastroenterology. 2022 03; 162(3):700-702. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/34954223) response cancer. Cell. 2021 12 09; 184(25):6119-6137.e26. View in: in a platinum-sensitive, BRCA2-mutated pancreatic cancer patient after earlier progression on placebo treatment on the POLO trial: a case report. J Gastrointest Oncol. 2021 Dec; 12(6):3133-3140. in: and risk of digestive system cancers: a prospective cohort study. Am 08; 114(5):1612-1624. microbiome in relation to pancreatic cancer risk in African Americans. Br J Cancer. 2022 02; 126(2):287-296. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/34718358) Low glycaemic 11; 599(7884):302-307. ductal adenocarcinoma: a pathway analysis of genome-wide Nutr. 2021 10 04; View deletion in CTRB2 inhibits chymotrypsin B2 activity and secretion and confers risk of pancreatic cancer. Am J Hum Genet. 2021 10 07; 108(10):1852-1865. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/34559995) Unrestrained eating behavior and risk A 09 04; 113(9):1186-1193. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/33739411) Retrospective Case Analysis of RAF Family Alterations in Pancreatic Cancer: Real-World Outcomes From Targeted and 2021; 5. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/34476331) Beyond the Front Line: Emerging Data for Maintenance Therapy in Pancreatic Cancer. 30(4):773-786. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/34511196) Opportunities for Utilization of DNA Repair Inhibitors in Homologous Recombination Repair-Deficient and Proficient Pancreatic Adenocarcinoma. the ESCRT Paralog Enzymes VPS4A and VPS4B in Cancers Harboring Loss of Chromosome 18q or 16q. Cell Rep. 2021 Jul Resistance Tumor Microenvironment in Patients with Resectable Pancreatic Cancer. Discov. 2021 08; 11(8):2014-2031. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/33727309) [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/33574088) Type 2 to Genome Med. 2021 02 01; 13(1):15. Implementing Systematic Genetic Counseling and Colorectal Cancers ESCRT Paralog Enzymes VPS4A and VPS4B in Cancers Harboring Loss of Chromosome 18q or 16q. Cell Rep. 2020 [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/33326793) Trajectory of CA19-9 Metabolic Patterns in the Pre-Diagnostic Period: Implications for Early Detection. Front Oncol. 2020; 10:596931. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/33344245) Composition, Spatial Characteristics, and Significance of Myeloid Cell Infiltration in Pancreatic Cancer. [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/33262135) Population-Scale CT-based Body Composition Analysis of a Large Outpatient Population Using Deep Learning to Derive Age-, Sex-, and Vitamin D3 Supplementation on Body Composition among Patients with Advanced or Metastatic Colorectal Cancer: A Randomized Trial. 10 01; 6(10):e202948. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/32789511) A Transcriptome-Wide Association Study Identifies Novel Candidate Susceptibility Genes for Pancreatic Cancer. J Natl Cancer in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/32967863) Prediagnostic Circulating Concentrations of Vitamin D Binding Protein and Survival among Patients with Colorectal Cancer. Cancer profiling to define cancer vulnerabilities and therapeutic mechanism of action. Nat Commun. 2020 08 27; 11(1):4296. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/32855387) The Mediterranean diet, plasma metabolome, and cardiovascular disease risk. Eur Heart J. 2020 07 21; 41(28):2645-2656. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/32406924) Genome-Wide Association Study Data Reveal Genetic Susceptibility to Chronic Inflammatory Intestinal Diseases and Pancreatic Ductal Adenocarcinoma Risk. Cancer Res. 2020 09 15; 80(18):4004-4013. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/32641412) Assessment of polygenic architecture and risk prediction based on common variants across fourteen cancers. Nat Commun. 2020 07 03; 11(1):3353. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/32620889) Altered RNA Splicing by Mutant p53 Activates Oncogenic RAS Signaling in Pancreatic Cancer. Cancer 38(2):198-211.e8. View Genome-Wide from risk of colorectal cancer: results from three large prospective cohort studies. Br J Cancer. 2020 09; 123(5):844-851. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/32541871) Insulin-Like Growth Factor-1 Receptor Expression and Disease Recurrence and Survival in Patients with Resected pembrolizumab and chemotherapy for pancreatic cancer: the COMBAT trial. Nat Med. 2020 06; 26(6):878-885. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/32451495) Genetic and Circulating Biomarker Data Improve Risk Prediction for Pancreatic Cancer in the General Population. Cancer a like Nat Chem Biol. 2020 06; 16(6):635-643. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/32251410) Response to the letter by Lai et al. regarding our manuscript \"Statin use and pancreatic cancer risk in two prospective cohort studies\". J Gastroenterol. 2020 04; 55(4):473-474. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/32060759) A phase 2 clinical trial of the heat shock protein 90 (HSP 90) inhibitor ganetespib in patients with refractory advanced esophagogastric Invest 2020 10; 38(5):1533-1539. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/31898183) Global, multicenter, of gemcitabine and gemcitabine plus AGS-1C4D4 in patients with previously untreated, 2013 Jul; 24(7):1792-1801. View in: Therapy is 10(1):104-123. View [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/31649109) Postdiagnosis Loss of Skeletal Muscle, but Not Adipose Tissue, Is Associated with Shorter Survival of Patients with Advanced Pancreatic Cancer. Cancer a small molecule antagonist of human chemokine (C-C motif) receptor 2 (PF-04136309) in first-line treatment of Agnostic Pathway/Gene Set Analysis of Association Data Identifies Associations for Pancreatic Cancer. J Natl Cancer Inst. 2019 Jun 01; 111(6):557-567. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/30541042) Influence of genetic variation in the vitamin D pathway on plasma 25-hydroxyvitamin D3 levels and survival among patients with metastatic colorectal cancer. Cancer Causes Control. 2019 Jul; 30(7):757-765. D3 Supplementation Survival Among With Advanced or Metastatic Colorectal Cancer: The SUNSHINE Randomized View 2019 05; 156(6):1560-1563. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/30926350) Family history of cancer, Ashkenazi Jewish ancestry, and pancreatic cancer risk. Br J Cancer. 04; Dietary Insulin Load and Cancer Recurrence and Survival in Patients With Stage III Colon Cancer: Findings From CALGB 89803 (Alliance). J 02 01; 111(2):170-179. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/30726946) Testing for Verification Bias Malignancy Risks for Side-Branch Intraductal Papillary Mucinous Neoplasms: A aspirin or non-aspirin nonsteroidal anti-inflammatory drugs is not associated with risk of incident pancreatic cancer in two large cohort studies. Gastroenterology. 2018 Aug 09. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/30099072) Reply. Gastroenterology. 2018 Aug 09. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/30098925) Germline cancer susceptibility gene variants, somatic second hits, and survival outcomes in patients with resected pancreatic cancer. Genet Med. 2019 01; exocrine function can drive wasting in 2018 06; in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/29925948) Real-time Genomic Characterization of Advanced to Cancer Discov. 2018 09; 8(9):1096-1111. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/29903880) Organoid Profiling Identifies Common Responders Chemotherapy in Cancer. Cancer Discov. 2018 09; 8(9):1112-1129. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/29853643) 04 25; 9(4):145. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/29691365) Association of Alterations in Main Driver Genes With Outcomes of Patients With Resected Pancreatic characterization of multi-cancer risk locus on chr5p15.33 reveals regulation Use of Statins Associates With Increased Survival Times of Patients With Pancreatic 2018 in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/29422604) Statin use and pancreatic cancer risk in two prospective cohort studies. J Gastroenterol. 2018 Aug; 53(8):959-966. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/29362938) Regular Use of Aspirin or Non-Aspirin Nonsteroidal Anti-Inflammatory Drugs Is Not Associated With Risk of Incident Pancreatic Cancer in Two Large Cohort Studies. Gastroenterology. 2018 04; 154(5):1380-1390.e5. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/29229401) Covariate selection 2017 adenocarcinoma: of disease 2017 Dec 05; 117(12):1874-1882. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/28982112) Aspirin exerts Oncotarget. 2017 Oct 20; 8(50):87379-87389. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/29152088) 'Borderline resectable pancreatic cancer: an evolving Oncol. 2017 Sep 01; 28(9):2067-2076. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/28407088) Influence of dietary insulin scores on survival in colorectal cancer patients. Br J Cancer. 2017 Sep 26; 117(7):1079-1087. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/28817837) Critical in oncology (ALLIANCE) trial A021501: preoperative extended chemotherapy vs. chemotherapy plus hypofractionated radiation therapy for borderline resectable adenocarcinoma of the head of the pancreas. BMC Cancer. 2017 Jul 27; 17(1):505. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/28750659) Long-term With Branch Duct Intraductal in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/28739282) Identifying the and low consumers. J Nutr Sci. 2017; 6:e34. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/29152238) Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway. Nature. 2017 07 27; 547(7664):453-457. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/28678785) Quantifying the tissues. Gut. 2018 03; 67(3):521-533. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/28634199) Patterns of Chemotherapy Use in a U.S.-Based Cohort of Patients with Metastatic Pancreatic Cancer. Oncologist. 2017 locus on and Variable Thresholding Improve Performance of Polygenic Risk Modeling Based on Genome-Wide Association Study Genet. 2016 Dec; in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/28036406) cancer risk locus reveals long-range interaction and allele-specific DIS3 2016 11 01; 25(21):4726-4738. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/28172817) Phase pharmacokinetics of the anti-MUC16 antibody-drug conjugate DMUC5754A in patients Cancer with Prediagnostic Plasma Levels of Leptin and Leptin Receptor Genetic Polymorphisms. Cancer Res. 2016 12 76(24):7160-7167. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/27780823) Leucocyte telomere length, genetic the TERT and risk of pancreatic cancer. Gut. 2017 06; 66(6):1116-1122. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/27797938) Three pancreatic identified on 1q32.1, 5p15.33 Oncotarget. 2016 Oct [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/27579533) Tissue of origin dictates branched-chain amino acid metabolism in mutant Kras-driven cancers. Science. 2016 Functional characterization of a cancer risk locus reveals long-range interaction and allele-specific effects on DIS3 expression. Mol Genet. 2016 Aug 30. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/27580880) Nurses' Health Study Contributions on the Epidemiology of Less Common Cancers: Endometrial, Ovarian, Pancreatic, and Hematologic. Am J Public Health. Sep; 106(9):1608-15. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/27459458) Cumulative consumption of branched-chain amino acids and incidence of type 2 diabetes. Int J Epidemiol. 2016 10; 45(5):1482-1492. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/27413102) 2016 20; mosaicism is and preferentially inactivated 06 7:11843. [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/27291797) [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/27197284) trial of ASG-5ME, a novel drug-antibody conjugate targeting SLC44A4, in patients with advanced pancreatic and gastric cancers. Invest New Drugs. 2016 06; 34(3):319-28. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/26994014) Impact of Pre-analytic Among Pancreatic Natl Inst. in Pancreatic Cancer: Will They Succeed on the Long, Littered Road to Early Detection Marker? Clin Chem. 2016 Feb; 62(2):307-9. View in: Heritability and Shared Heritability Based on Genome-Wide Association Studies for Thirteen Cancer Types. J Natl Cancer Inst. 2015 Dec; 107(12):djv279. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/26464424) Central adiposity, obesity during early adulthood, and pancreatic cancer mortality in a pooled analysis of cohort studies. Ann Oncol. 2015 at 17q25.1 susceptibility 2015 47(8):911-6. View gene harbors multiple variants associated with pancreatic cancer susceptibility. Int J Cancer. 2015 Nov 01; 137(9):2175-83. Reply to Y. Mao et Clin Oncol. 2015 Jun 20; 33(18):2121-2. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/25940723) Characterization of large structural genetic mosaicism in human autosomes. Am J Hum Genet. 2015 Mar 05; 96(3):487-97. View [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/25748358) Correlation of CT patterns of primary intrahepatic cholangiocarcinoma at the time of presentation with the metastatic spread and clinical outcomes: retrospective study of 92 patients. Abdom Imaging. 2014 Dec; 39(6):1193-201. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/24869789) Survival among with long-standing diabetes in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/25403204) Elevation of circulating branched-chain amino acids is an early event in human pancreatic adenocarcinoma development. Nat Med. 2014 10; 20(10):1193-1198. View in: A phase I and pharmacokinetic study of ganetespib (STA-9090) in advanced hepatocellular carcinoma. Drugs. 2015 Feb; 33(1):128-37. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/25248753) Genome-wide association study identifies subset-based association analysis across different cancer types identifies multiple independent risk loci in the TERT-CLPTM1L region on chromosome 5p15.33. Managing advanced colorectal cancer: have reached the PEAK with current therapies? Clin Oncol. 2014 Jul 20; 32(21):2200-2. pharmacodynamic to pancreatic cancer and do not reciprocally affect Jun; in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/24642353) Nut consumption and risk of pancreatic cancer in women. Br J Cancer. 2013 Nov 26; 109(11):2911-6. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/24149179) Prediagnostic body mass index Oncol. 2013 Nov 20; 31(33):4229-34. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/24145341) An absolute risk model to identify individuals at elevated risk for pancreatic cancer in the general population. PLoS One. 2013; 8(9):e72311. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/24058443) Delaying chemoradiation until after completion of adjuvant chemotherapy for pancreatic cancer may not impact local control. metabolomic profiles among men and women in 2 large cohort studies. Clin Chem. 2013 Nov; 59(11):1657-67. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/23897902) Hyperglycemia, impaired and risk of pancreatic cancer. J 2013 Jul 17; in metastatic colorectal cancer: results of a phase I study of pertuzumab plus cetuximab in cetuximab-refractory patients. Invest New Drugs. 2014 Feb; 32(1):113-22. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/23568716) Inflammatory plasma markers and pancreatic cancer risk: a prospective study of five U.S. cohorts. Epidemiol Prev. 2013 5p15.33, and associated 42(2):209-15. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/23295781) multicenter, of gemcitabine and gemcitabine plus AGS-1C4D4 in patients with previously untreated, Ann Oncol. 2013 Jul; 24(7):1792-1801. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/23448807) Polymorphisms in genes related to one-carbon metabolism are not related to pancreatic cancer in PanScan and PanC4. Cancer Causes Control. 2013 24(3):595-602. [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/23334854) Molecular pathological epidemiology of epigenetics: emerging integrative science to analyze environment, host, and disease. Mod Pathol. 2013 Apr; 2013; 18(1):64-72. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/23287880) A prospective study of plasma adiponectin and pancreatic cancer risk in five US cohorts. J Natl Cancer Inst. 2013 Jan 16; 105(2):95-103. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/23243202) association study of adenocarcinoma. Gut. 2014 Jan; 63(1):152-60. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/23180869) Diabetes and risk of pancreatic cancer: a pooled analysis from the pancreatic cancer cohort consortium. Cancer Causes Control. 2013 Jan; 24(1):13-25. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/23112111) Phase I study of pasireotide and everolimus (RAD001) in advanced 19(5):615-23. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/22736724) ABO blood group and risk of coronary heart disease in two prospective cohort studies. Arterioscler Thromb Vasc Biol. 2012 cetuximab, irinotecan, and vandetanib (ZD6474) as therapy for patients clonal mosaicism and its relationship to aging and cancer. Nat Genet. 2012 May 06; 44(6):651-8. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/22561519) Pathway analysis of genome-wide association study data highlights pancreatic development genes as susceptibility factors for pancreatic cancer. Carcinogenesis. 2012 Jul; 33(7):1384-90. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/22523087) ABO blood group and breast cancer incidence and survival. Int J Cancer. 2012 May 01; 130(9):2129-37. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/21633955) Panitumumab in [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/22665454) 2012 Jan; 21(1):82-91. of MKC-1, an inhibitor of importin-\u00df, tubulin, and the mTOR pathway in patients with unresectable or metastatic pancreatic cancer. Invest New Drugs. 2012 Aug; 30(4):1614-20. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/21800081) Dietary insulin load, dietary insulin index, and risk of pancreatic cancer. Am J Clin Nutr. 2011 Sep; 94(3):862-8. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/21775564) Comparison of autologous stem cell transplantation versus consolidation chemotherapy for patients with cytogenetically normal acute myeloid leukemia (CN-AML) and safety of a novel hedgehog pathway inhibitor, in combination with gemcitabine in patients (pts) with metastatic pancreatic cancer. 2011 May 20; 29(15_suppl):4114. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/28021279) Updated results of a phase I study of pasireotide (SOM230) in combination with everolimus (RAD001) in patients (pts) with advanced neuroendocrine tumors (NET). Clin Oncol. randomized trial comparing gemcitabine (G) with. G plus AGS-1C4D4 (A) in patients (pts) with metastatic pancreatic cancer Rapid progression of combined hepatocellular carcinoma and cholangiocarcinoma. Cancer Imaging. 2011 Mar 31; 11:37-41. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/21507775) ABO blood group and II trial of single-agent cetuximab in advanced esophageal and gastric adenocarcinoma. Ann Oncol. 2011 Jun; 22(6):1367-1373. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/21217058) Variant alleles, secretor status, and risk of pancreatic cancer: results from the pancreatic cancer cohort Prev. 2010 Dec; 19(12):3140-9. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/20971884) Prospective study of ABO blood type and the risk of pulmonary embolism in two large cohort studies. Thromb Haemost. 2010 Nov; 104(5):962-71. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/20886188) Family history of cancer and risk of pancreatic cancer: a pooled analysis from the Pancreatic Cancer Cohort Consortium (PanScan). Int J Cancer. 2010 Sep 01; 127(6):1421-8. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/20049842) Anthropometric measures, body mass index, and pancreatic cancer: a pooled analysis from the Pancreatic Cancer Cohort Consortium (PanScan). Arch Intern Med. 2010 May 10; 170(9):791-802. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/20458087) Predicted vitamin D status and pancreatic cancer risk in two prospective cohort studies. Br J Cancer. 2010 Apr 27; 102(9):1422-7. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/20389298) A step forward in the treatment of advanced biliary tract cancer. N Engl J Med. 2010 Apr 08; 362(14):1335-7. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/20375411) Alcohol intake and pancreatic cancer: a pooled analysis from the pancreatic cancer cohort consortium (PanScan). Cancer Causes Control. 2010 Aug; 21(8):1213-25. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/20373013) ABO blood group and incidence of epithelial ovarian cancer. Int J Cancer. 2011 Jan 15; 128(2):482-6. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/20309936) Pancreatic cancer risk and ABO blood group alleles: results from the pancreatic cancer cohort consortium. Cancer Res. 2010 Feb 01; 70(3):1015-23. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/20103627) A genome-wide association Clinical problem-solving. The writing on the wall. N Engl J Med. 2009 Oct 01; 361(14):1387-92. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/19797286) Interactive medical case. The writing on the wall. N Engl J Med. 2009 Sep 10; 361(11):e19. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/19750587) Interaction of molecular markers and physical activity on mortality in patients with colon cancer. Clin Cancer Res. 2009 Sep 15; 15(18):5931-6. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/19723652) Prospective study of predictors of vitamin D status and survival in patients with colorectal cancer. Br J Cancer. 2009 Sep 15; 101(6):916-23. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/19690551) Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer. Nat Genet. 2009 Jul 15; 101(14):972-3. View cohort study of STMN1 expression in colorectal cancer: body mass index and prognosis. Am J Gastroenterol. 2009 Aug; 104(8):2047-56. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/19513025) A cohort study of p27 localization in colon cancer, body mass index, and patient survival. Cancer Epidemiol Biomarkers Prev. 2009 Jun; 18(6):1849-58. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/19505918) ABO group and the risk of pancreatic cancer. J Natl Cancer Inst. 2009 Mar and metastatic colorectal cancer: results from intergroup trial N9741. Dec 15; 14(24):8263-9. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/19073970) Insulin, the insulin-like growth factor axis, and mortality in patients with nonmetastatic colorectal cancer. J Clin [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/19047305) Prediagnostic plasma folate and the risk of death in patients with colorectal cancer. J Clin Oncol. 2008 Jul 01; 26(19):3222-8. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/18591557) Phase II study of RAD001 in previously treated patients with metastatic pancreatic cancer. Oncol. 2008 C-peptide 2007 Oct; 16(10):2101-9. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/17905943) Circulating growth factor binding protein-1 and the risk of pancreatic cancer. Cancer Res. 2007 Aug 15; 67(16):7923-8. View and homocysteine and pancreatic cancer risk in four large cohorts. Cancer Res. 2007 Jun 01; 67(11):5553-60. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/17545639) Circulating insulin-like growth factor axis and the risk of pancreatic cancer in four prospective cohorts. Br J Cancer. 2007 Jul 02; 97(1):98-104. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/17533398) Adjuvant treatment of colorectal J 2007 May-Jun; 57(3):168-85. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/17507442) CpG island methylation, response to combination chemotherapy, and patient survival in advanced microsatellite stable colorectal carcinoma. Virchows plasma C-peptide and pancreatic cancer risk in men and women. Submitted. 2006. Insulin-like growth factor binding protein-1 and the risk of pancreatic cancer in four prospective cohorts. Submitted. 2006. CpG island methylation, response to combination chemotherapy, and patient survival in advanced microsatellite stable colorectal cancer. Submitted. 2006. Plasma folate, vitamins B6, B12, and homocysteine and pancreatic cancer risk in four large cohorts. Submitted. 2006. Circulating insulin-like growth factor axis and the risk of pancreatic cancer in four prospective cohorts. Submitted. 2006. Phase I study of gefitinib plus FOLFIRI in previously untreated patients with metastatic Jun-Jul; 10(6):449-56. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/15967838) Identifying mutation of the FLT3 tyrosine kinase "}